Dr. Reddy’s June 2025 6-K: Board Meeting Intimation Only

Rhea-AI Filing Summary

Form 6-K overview

Dr. Reddy’s Laboratories Limited (RDY) filed a Form 6-K with the SEC dated 23 June 2025. The submission contains one exhibit—Exhibit 99.1: “Intimation regarding Board Meeting.” No financial statements, earnings figures, or major transactional details accompany the notice. The company confirms it files annual reports on Form 20-F and is not claiming the Rule 12g3-2(b) exemption. The filing is signed by Company Secretary K Randhir Singh from the Hyderabad headquarters.

Because the document simply alerts investors that a board meeting will be convened, without disclosing the meeting date, agenda, or potential resolutions, it offers no material information likely to impact valuation or strategy.

Insights

Financial Analyst

TL;DR: Routine Form 6-K; only board-meeting notice; no financial data—neutral for investors.

This 6-K functions as a procedural filing. The lone exhibit indicates management will hold a board meeting, but crucial details—date, agenda items, possible dividend or earnings discussions—are absent. With no operational, financial, or strategic disclosures, market impact is expected to be negligible. Investors should await follow-up releases for substantive information.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

June, 2025

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   x                                  Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes   ¨                                  No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation regarding Board Meeting

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED
	(Registrant)
Date: June 23, 2025	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

FAQ

Why did Dr. Reddy's Laboratories (RDY) file a Form 6-K in June 2025?

The company furnished the form to provide Exhibit 99.1, an intimation of an upcoming Board meeting.

Does the June 2025 6-K include any financial or earnings data for RDY?

No. No financial statements, earnings figures, or guidance were included in this filing.

Is Dr. Reddy's claiming the Rule 12g3-2(b) exemption in this filing?

No. The company specifically checked “No” regarding furnishing information under Rule 12g3-2(b).

What is Exhibit 99.1 listed in RDY's Form 6-K?

Exhibit 99.1 is titled “Intimation regarding Board Meeting.” It serves as advance notice but offers no further details.

Who signed the June 23 2025 Form 6-K on behalf of Dr. Reddy's?

The filing was signed by K Randhir Singh, Company Secretary.